Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab
Maria Cristina Puzzolo, Giulia Radice, Nadia Peragine, Maria Stefania De Propris, Paola Mariglia, Marco Vignetti, Antonella Vitale, Renato Bassan, Mario Annunziata, Gianluca Gaïdano, Alessandro Rambaldi, Sabina Chiaretti, Anna Guarini, Robin Foà
Topics & Concepts
DasatinibBlinatumomabLymphoblastic LeukemiaImmune modulationMedicineImmune systemCancer researchImmunologyLeukemiaImatinibMyeloid leukemiaAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research